JP2021518365A5 - - Google Patents

Info

Publication number
JP2021518365A5
JP2021518365A5 JP2020549702A JP2020549702A JP2021518365A5 JP 2021518365 A5 JP2021518365 A5 JP 2021518365A5 JP 2020549702 A JP2020549702 A JP 2020549702A JP 2020549702 A JP2020549702 A JP 2020549702A JP 2021518365 A5 JP2021518365 A5 JP 2021518365A5
Authority
JP
Japan
Prior art keywords
cells
genome
expression cassette
derived
optionally
Prior art date
Application number
JP2020549702A
Other languages
English (en)
Japanese (ja)
Other versions
JP7535944B2 (ja
JP2021518365A (ja
JPWO2019178550A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/022595 external-priority patent/WO2019178550A1/en
Publication of JP2021518365A publication Critical patent/JP2021518365A/ja
Publication of JP2021518365A5 publication Critical patent/JP2021518365A5/ja
Publication of JPWO2019178550A5 publication Critical patent/JPWO2019178550A5/ja
Priority to JP2024047652A priority Critical patent/JP2024073654A/ja
Application granted granted Critical
Publication of JP7535944B2 publication Critical patent/JP7535944B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020549702A 2018-03-16 2019-03-15 神経栄養因子の誘導可能な発現のための方法及び組成物 Active JP7535944B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024047652A JP2024073654A (ja) 2018-03-16 2024-03-25 神経栄養因子の誘導可能な発現のための方法及び組成物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862644332P 2018-03-16 2018-03-16
US62/644,332 2018-03-16
US201862773752P 2018-11-30 2018-11-30
US62/773,752 2018-11-30
PCT/US2019/022595 WO2019178550A1 (en) 2018-03-16 2019-03-15 Methods and compositions for inducible expression of neurotrophic factors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024047652A Division JP2024073654A (ja) 2018-03-16 2024-03-25 神経栄養因子の誘導可能な発現のための方法及び組成物

Publications (4)

Publication Number Publication Date
JP2021518365A JP2021518365A (ja) 2021-08-02
JP2021518365A5 true JP2021518365A5 (https=) 2022-02-17
JPWO2019178550A5 JPWO2019178550A5 (https=) 2022-02-17
JP7535944B2 JP7535944B2 (ja) 2024-08-19

Family

ID=67907321

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020549702A Active JP7535944B2 (ja) 2018-03-16 2019-03-15 神経栄養因子の誘導可能な発現のための方法及び組成物
JP2024047652A Pending JP2024073654A (ja) 2018-03-16 2024-03-25 神経栄養因子の誘導可能な発現のための方法及び組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024047652A Pending JP2024073654A (ja) 2018-03-16 2024-03-25 神経栄養因子の誘導可能な発現のための方法及び組成物

Country Status (7)

Country Link
US (1) US12258571B2 (https=)
EP (1) EP3765058A4 (https=)
JP (2) JP7535944B2 (https=)
KR (1) KR102843346B1 (https=)
CN (1) CN111867617A (https=)
AU (1) AU2019236288B2 (https=)
WO (1) WO2019178550A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190018000A1 (en) 2016-01-12 2019-01-17 Cedars-Sinai Medical Center A method of non destructive monitoring of biological processes in microfluidic tissue culture systems
CA3012042A1 (en) 2016-01-26 2017-08-03 Cedars-Sinai Medical Center Systems and methods for in vivo dual recombinase-mediated cassette exchange (drmce) and disease models thereof
WO2018140647A1 (en) 2017-01-25 2018-08-02 Cedars-Sinai Medical Center In vitro induction of mammary-like differentiation from human pluripotent stem cells
US11767513B2 (en) 2017-03-14 2023-09-26 Cedars-Sinai Medical Center Neuromuscular junction
US11414648B2 (en) 2017-03-24 2022-08-16 Cedars-Sinai Medical Center Methods and compositions for production of fallopian tube epithelium
US12258571B2 (en) 2018-03-16 2025-03-25 Cedars-Sinai Medical Center Methods and compositions for inducible expression of neurotrophic factors
EP4700387A2 (en) 2018-03-23 2026-02-25 Cedars-Sinai Medical Center Methods of use of islet cells
EP3775161A4 (en) 2018-04-06 2022-04-06 Cedars-Sinai Medical Center NEURODEGENERATIVE DISEASE MODELS DERIVED FROM HUMAN PLURIPOTENTIC STEM CELLS ON A MICROFLUIDIC CHIP
US11981918B2 (en) 2018-04-06 2024-05-14 Cedars-Sinai Medical Center Differentiation technique to generate dopaminergic neurons from induced pluripotent stem cells
EP3787613B1 (en) 2018-04-30 2026-03-11 Cedars-Sinai Medical Center Pkc activation for use in treating early onset sporadic parkinson's disease
WO2020084168A1 (en) * 2018-10-26 2020-04-30 Icm (Institut Du Cerveau Et De La Moelle Épinière) Tetracycline compound for treating drug-induced dyskinesia
AU2020370288B2 (en) * 2019-10-22 2026-02-12 Cedars-Sinai Medical Center Cortical neural progenitor cells from iPSCs
US20230047254A1 (en) * 2019-12-29 2023-02-16 Gloriana Therapeutics Mammalian Cells Secreting GDNF and Their Therapeutic Use
KR20220061403A (ko) * 2020-11-06 2022-05-13 (주) 에스바이오메딕스 다능성 줄기세포 유래 신경전구세포를 포함하는 퇴행성 뇌질환 치료용 약학적 조성물
CN121420065A (zh) * 2023-06-29 2026-01-27 香港大学 用于在肝脏或肝癌中的可控转录的方法
GB202312699D0 (en) * 2023-08-18 2023-10-04 Cambridge Entpr Ltd Controllable expression in mammalian cells
WO2025091023A1 (en) * 2023-10-27 2025-05-01 Northwestern University Engineered cell transfected by all-in-one vector for therapeutic agents production and delivery and applications thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7575924B2 (en) 2000-11-13 2009-08-18 Research Development Foundation Methods and compositions relating to improved lentiviral vectors and their applications
US20030084468A1 (en) 2001-09-05 2003-05-01 Economides Aris N. Methods of expressing transgenes
WO2003090689A2 (en) * 2002-04-25 2003-11-06 Wisconsin Alumni Research Foundation Neurodegenerative disorder treatment using gdnf secreting neural cells
GB2404382B (en) 2003-07-28 2008-01-30 Oxitec Ltd Pest control
US20120107284A1 (en) * 2006-06-30 2012-05-03 Elena Kozlova Stem cells for transplantation and methods for production thereof
US20100077495A1 (en) 2006-12-21 2010-03-25 Davis David P Compositions and methods for the expression of nucleic acids
US8592211B2 (en) * 2009-03-20 2013-11-26 The Rockefeller University Enhanced PiggyBac transposon and methods for transposon mutagenesis
US20120107938A1 (en) 2009-06-29 2012-05-03 University Of Basel Methods and kits for high efficiency engineering of conditional mouse alleles
WO2013155222A2 (en) * 2012-04-10 2013-10-17 The Regents Of The University Of California Brain-specific enhancers for cell-based therapy
CN102816793B (zh) * 2012-08-22 2014-09-10 陕西师范大学 单载体双向启动的Tet-on诱导表达系统及其构建方法和应用
JP2016508520A (ja) 2013-02-15 2016-03-22 インターナショナル ステム セル コーポレイション 神経変性疾患の治療のための、ヒト多能性幹細胞に由来する神経細胞の使用
US10519421B2 (en) 2013-03-21 2019-12-31 Kyoto University Induction of motor neurons from pluripotent stem cells
WO2014204724A1 (en) 2013-06-17 2014-12-24 The Broad Institute Inc. Delivery, engineering and optimization of tandem guide systems, methods and compositions for sequence manipulation
WO2015143342A1 (en) 2014-03-21 2015-09-24 Cellular Dynamics International, Inc. Production of midbrain dopaminergic neurons and methods for the use thereof
CA2943296C (en) * 2014-03-21 2022-10-18 The Sydney Children's Hospitals Network (Randwick And Westmead) (Incorporating The Royal Alexandra Hospital For Children) Stable gene transfer to proliferating cells
EP3122370A1 (en) 2014-03-28 2017-02-01 Buck Institute for Research on Aging Methods and compositions for modulating the immune system
AU2015279552B2 (en) 2014-06-27 2021-01-21 Angiocrine Bioscience, Inc. Neural cells expressing adenovirus E4ORF1, and methods of making and using the same
JP6928604B2 (ja) * 2015-11-04 2021-09-01 フェイト セラピューティクス，インコーポレイテッド 万能性細胞のゲノム改変
CA3012042A1 (en) 2016-01-26 2017-08-03 Cedars-Sinai Medical Center Systems and methods for in vivo dual recombinase-mediated cassette exchange (drmce) and disease models thereof
US10221395B2 (en) 2016-06-16 2019-03-05 Cedars-Sinai Medical Center Efficient method for reprogramming blood to induced pluripotent stem cells
US12258571B2 (en) 2018-03-16 2025-03-25 Cedars-Sinai Medical Center Methods and compositions for inducible expression of neurotrophic factors
KR20220024527A (ko) 2019-06-17 2022-03-03 세다르스-신나이 메디칼 센터 생체내 이중 재조합효소-매개된 카세트 교환 (dRMCE)을 위한 시스템 및 방법 그리고 이들의 질환 모델

Similar Documents

Publication Publication Date Title
JP2021518365A5 (https=)
JP2024073654A5 (https=)
Park et al. Human neural stem cells over-expressing choline acetyltransferase restore cognition in rat model of cognitive dysfunction
JPWO2019178550A5 (https=)
Dirren et al. SOD1 silencing in motoneurons or glia rescues neuromuscular function in ALS mice
US10907138B2 (en) TATk-CDKL5 fusion proteins, compositions, formulations, and use thereof
Lee et al. miR-381 attenuates peripheral neuropathic phenotype caused by overexpression of PMP22
Perego et al. Current understanding of and emerging treatment options for spinal muscular atrophy with respiratory distress type 1 (SMARD1)
KR101749138B1 (ko) 신경질환 예방 또는 치료를 위한 aimp2-dx2를 포함하는 약학 조성물 및 이의 용도
KR20240110849A (ko) Aadc/gdnf 폴리뉴클레오티드 및 이의 파킨슨병 치료에 있어서의 용도
US20150111946A1 (en) Methods for delivery to the central nervous system of nucleic acid nanoparticles to treat central nervous system disorders
Puranik et al. Exploring the role of gene therapy for neurological disorders
EP3754025A1 (en) Mesenchymal stem cells expressing brain-derived neurotrophic factor and use thereof
Zhu et al. Neuroprotective effects of human umbilical cord-derived mesenchymal stem cells from different donors on spinal cord injury in mice
Jiang et al. Gene therapy using human FMRP isoforms driven by the human FMR1 promoter rescues fragile X syndrome mouse deficits
EP3119406B1 (en) Methods for improving cognitive function via modulation of quinone reductase 2
CA3085576A1 (en) Peptides and other agents for treating pain and increasing pain sensitivity
CN108853505B (zh) 钾离子通道抑制剂治疗抑郁症的用途和药物组合物
Sharma Innovative genoceuticals in human gene therapy solutions: challenges and safe clinical trials of orphan gene therapy products
US10220077B2 (en) Combination treatment for amyotrophic lateral sclerosis (ALS)
Lin et al. Exercise alleviates cognitive dysfunction in Alzheimer’s disease mice via skeletal muscle-derived extracellular vesicles that enhance plaque clearance by microglia
Wang et al. Viral vectors in neurodegenerative diseases: immune responses and therapeutic applications
Ye et al. Peptide OM-LV20 demonstrates neuroprotective effects by attenuating mitochondria-mediated neuronal apoptosis and dysfunction in mice with traumatic brain injury.
US20240254174A1 (en) Rabies viral glycoprotein compositions and methods of use
KR20250047689A (ko) 알파-시누클레인 응집 억제용 조성물 및 응집억제 방법